Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy

Burke, Aidan M.Carrasquilla, Michael2022-11-302022-11-302022-01-122234-943Xhttp://hdl.handle.net/10342/11791en-USbrain metastasesimmunotherapyradiation necrosisVolume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint TherapyArticle10.3389/fonc.2021.794615